YAP1 and cholangiocarcinoma: Thus, whereas hyperactivation of YAP/TAZ signalling is associated with cancer development, the accumulation of YAP/TAZ in the peritumoral hepatocytes in a cholangiocarcinoma mouse model was found to reduce tumour burden by triggering cell death in cancer cells.